<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01849809</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#2010-001</org_study_id>
    <nct_id>NCT01849809</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Gamma Capsulotomy in Intractable OCD</brief_title>
  <official_title>Safety and Effectiveness of Gamma Capsulotomy in Intractable Obsessive Compulsive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A research study of the effectiveness and safety of gamma knife ventral capsulotomy in
      patients with severe intractable obsessive-compulsive disorder (OCD).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 1993</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open Label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Severity Scale</measure>
    <time_frame>Baseline to 5 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Obsessive Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Gamma Ventral Capsulotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gamma Ventral Capsulotomy</intervention_name>
    <arm_group_label>Gamma Ventral Capsulotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. OCD, diagnosed by Structured Clinical Interview for DSM-IV (SCID-IV), judged of
             disabling severity with a Yale-Brown Obsessive Compulsive Scale (YBOCS) score of at
             least 30 and a Social and Occupational Functioning Assessment Scale (SOFAS) score of
             45 or less.

          2. Persistence of severe symptoms and impairment for five or more years despite: 1. at
             least three adequate (≥3 months at the maximum tolerated dose) serotonin transporter
             inhibitor trials (fluoxetine, sertraline, fluvoxamine, paroxetine, citalopram,
             escitalopram, or clomipramine) alone or in combination with, 2. adequate behavior
             therapy (≥20 sessions of expert exposure and response prevention), and 3. augmentation
             of one of the selective SRIs with clomipramine, a neuroleptic, and clonazepam.

          3. Age between 18 and 65 years.

          4. Able to understand and comply with instructions.

          5. Able to give fully informed, written consent in the judgment of the Consent Monitor.

          6. Either drug free or on a stable drug regimen for at least 6 weeks.

          7. Good general health.

          8. A family member or significant other is available and willing to communicate with the
             research team if the patient's clinical status worsens.

          9. The local referring psychiatrist is willing to provide ongoing care.

        Exclusion Criteria:

          1. Current or past psychotic disorder.

          2. Full-scale IQ below 85.

          3. A clinical history of bipolar mood disorder.

          4. Any current clinically significant neurological disorder or medical illness affecting
             brain function, other than tic disorders or Tourette syndrome.

          5. Any clinically significant abnormality on preoperative magnetic resonance imaging
             (MRI).

          6. Inability to undergo presurgical MRI (cardiac pacemaker, pregnancy, metal in body,
             severe claustrophobia.

          7. Current or unstably remitted substance abuse, dependence, or a positive urine
             toxicology screen.

          8. Pregnancy and women of childbearing age not using effective contraception.

          9. Unable to adhere to operational and administrative study requirements (in the
             investigators' judgment).

         10. Clinical history of severe personality disorder.

         11. Imminent risk of suicide (in the investigators' judgment).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Rasmussen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2013</study_first_submitted>
  <study_first_submitted_qc>May 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2013</study_first_posted>
  <last_update_submitted>August 9, 2017</last_update_submitted>
  <last_update_submitted_qc>August 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Butler Hospital</investigator_affiliation>
    <investigator_full_name>Steven Rasmussen</investigator_full_name>
    <investigator_title>Medical Director, Butler Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

